Clinical evaluation of urine laminin-γ2 monomer as a potent biomarker for non-muscle invasive bladder cancer.
Karashima T, Umemoto S, Kishida T, Osaka K, Nakagawa M, Yoshida E, Yoshimura T, Sakaguchi M, Nishimoto H, Tai M, Inoue K, Seiki M, Koshikawa N, Shuin T.
Karashima T, et al. Among authors: nishimoto h.
Cancer Med. 2023 Feb;12(3):2453-2462. doi: 10.1002/cam4.5087. Epub 2022 Aug 4.
Cancer Med. 2023.
PMID: 35924681
Free PMC article.